[A.A.DE.W1.S1.IMC.T.A.FA.D.F51A___ES.ALL.EUR.I._X._X.C21.1] Direct investment abroad / Equity in the narrow sense (other than reivestment of earnings and other equity) / Asset Liability-Principle (ALP) / Assets / Rest of the world / Manufacture of basic pharmaceutical products and pharmaceutical preparations / Activity of the direct investor
Updated on DBnomics on August 30, 2024 (3:36 AM)
- from
- 2008=34.84
- to
- 2023=NA
- min:
- -680.953
- max:
- 1,050.27
- avg:
- 218.201
- σ:
- 591.668
Loading chart
| Period | Value | [BBK_DIFF_Y] | [BBK_OBS_STATUS] |
|---|---|---|---|
| 2008 | 34.84 | ||
| 2009 | 136.395 | 291.5 | |
| 2010 | 24.1 | -82.3 | |
| 2011 | -680.953 | -2925.5 | |
| 2012 | 911.631 | 233.9 | |
| 2013 | -669.889 | -173.5 | |
| 2014 | 724.238 | 208.1 | |
| 2015 | NA | K | |
| 2016 | NA | K | |
| 2017 | 433.176 | ||
| 2018 | NA | K | |
| 2019 | NA | K | |
| 2020 | NA | K | |
| 2021 | 1050.27 | ||
| K | |||
| K |
| Dimension | Dimension value |
|---|---|
| [BBK_STD_FREQ] Frequency (BBk) | [A] Annual |
| [BBK_ESFDI_MEASURE_PRINCIPLE] Measurement principle | [A] Asset/Liability principle |
| [BBK_STD_REF_AREA] Area (countries, list of countries), BBk only | [DE] Germany |
| [BBK_ES_COUNTERPART_AREA] Area (countries, list of countries), BBk only | [W1] Rest of the World |
| [BBK_ES_REF_SECTOR] Resident sector of the compiling economy | [S1] Total economy |
| [BBK_ESFDI_LEVEL_COUNTERPART] Level of Counterpart | [IMC] Immediate counterpart (Immediate investor or immediate host, primary direct investment) |
| [BBK_ES_FLOW_STOCK_ENTRY] Transaction flow, position (stock), or a change in position not due to transactions | [T] Transactions |
| [BBK_ES_ACCOUNTING_ENTRY] Accounting entry (asset, liability, net) | [A] Assets (Net Acquisition of) |
| [BBK_ES_INT_ACC_ITEM] International account item | [FA] Financial account |
| [BBK_ES_FUNCTIONAL_CAT] Functional category | [D] Direct investment |
| [BBK_ES_INSTR_ASSETS_CLASSIF] Type of financial instrument | [F51A___ES] Equity in the narrow sense [national publication] |
| [BBK_ESFDI_TYPE_ENTITY] Type of entity | [ALL] All resident units |
| [BBK_ES_UNIT_MEASURE] Unit of measure | [EUR] Euro |
| [BBK_ESFDI_RELATIONSHIP] FDI relationship | [I] Influence >=10% of voting power |
| [BBK_ES_VALUATION] Method of valuation | [_X] Not allocated/unspecified (including all kinds of valuation methods) |
| [BBK_ESFDI_STAT_UNIT] Statistical unit | [_X] Unspecified statistical units |
| [BBK_ESFDI_ACTIVITY] Industrial activity, NACE ans ISIC | [C21] Manufacture of basic pharmaceutical products and pharmaceutical preparations |
| [BBK_ESFDI_ACTIVITY_ALLOC] Activity allocation | [1] Activity of the direct investor |